BC
Boxer Capital Portfolio holdings
AUM
$2.04B
1-Year Return
108.35%
This Quarter Return
+31.1%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$901M
AUM Growth
+$18M
(+2%)
Cap. Flow
-$91.2M
Cap. Flow
% of AUM
-10.12%
Top 10 Holdings %
Top 10 Hldgs %
81.99%
Holding
29
New
3
Increased
5
Reduced
1
Closed
5
Top Buys
| 1 |
AMRN
Amarin Corp
AMRN
|
$21.2M |
| 2 |
PTC Therapeutics
PTCT
|
$12M |
| 3 |
DBVT
DBV Technologies
DBVT
|
$9.77M |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$6.13M |
| 5 |
Solid Biosciences
SLDB
|
$4.79M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$49.6M |
| 2 |
Viking Therapeutics
VKTX
|
$35.6M |
| 3 |
Madrigal Pharmaceuticals
MDGL
|
$26.6M |
| 4 |
MacroGenics
MGNX
|
$25.7M |
| 5 |
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
|
$20.1M |
Sector Composition
| 1 | Healthcare | 95.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
MacroGenics
MGNX
$126M
| – | – |
-1,245,000
| Closed | -$25.7M |
|
|
27
Sarepta Therapeutics
SRPT
$1.96B
| – | – |
-375,000
| Closed | -$49.6M |
|
|
28
Viking Therapeutics
VKTX
$3.03B
| – | – |
-3,750,000
| Closed | -$35.6M |
|
|
ONCT
29
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| – | – |
-9,357
| Closed | -$20.1M |
|